The BMS, FSRH, RCGP and RCOG have released a position statement on the supply shortages of Hormone Replacement Therapy (HRT) To read the full statement please click here
For a balanced and authoritative 6 minute summary of the current situation concerning HRT shortages and testosterone for women, listen to Dr Paula Briggs, Chair Elect of the British Menopause Society, talking to Emma Barnett on Radio 4 Woman's Hour on 4 May 2022. Click here to listen. (32:40 - 39:00)
The British Menopause Society welcomes the further high-profile discussions about menopause and the role of HRT. The menopause transition can have a significant impact on many women, with more than 75% experiencing menopausal symptoms and a quarter describing their symptoms as severe. A third experience long-term symptoms, which may last as much as seven years [...]
Serious Shortage Protocols (SSPs) issued to limit dispensing to 3 months’ supply of Oestrogel®, Ovestin® cream and Premique Low Dose® to ensure women across the UK will be able to more reliably access Hormone Replacement Therapy (HRT) products. Women will only pay for prescriptions if they are dispensed in full meaning they will not face [...]
The British Menopause Society very much welcomes the appointment of Madelaine McTernan CB, the Vaccine Taskforce Director General, as head of the new HRT Supply Taskforce. The HRT shortages have had a significant impact on many women and any action taken to resolve this issue would be a very positive step. The BMS looks forward [...]
Post Reproductive Health is a MEDLINE indexed, peer reviewed source of news, research and opinion. Aimed at all those involved in the field of post reproductive health study and treatment, it is a vital resource for all practitioners and researchers. As the official journal of the British Menopause Society (BMS), Post Reproductive Health has a [...]
The UK National Osteoporosis Guideline Group (NOGG) has just launched its new UK Guideline for ‘The Prevention and Treatment of Osteoporosis’, which has been endorsed by NICE. This clinical guideline reviews the assessment and diagnosis of osteoporosis, the therapeutic interventions available and the approaches for the prevention of fragility fractures, in postmenopausal women, and in [...]
To read the full report, please click here which will take you to the RCOG website.
The British Menopause Society has issued this further update on HRT product availability to provide guidance to BMS members and clinical practitioners on the current availability of HRT products. The update shows good availability of most HRT products.
The new BMS PPMC Resources Toolkit brings together the huge array of evidence-based, peer reviewed resources already available on the BMS and WHC websites, to help you answer the key questions in menopause care. It is both comprehensive and easy to use. The Toolkit includes videos, consensus statements, infographics, tools for clinicians and fact sheets [...]
